BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Protic DD, Aishworiya R, Salcedo-Arellano MJ, Tang SJ, Milisavljevic J, Mitrovic F, Hagerman RJ, Budimirovic DB. Fragile X Syndrome: From Molecular Aspect to Clinical Treatment. Int J Mol Sci 2022;23:1935. [PMID: 35216055 DOI: 10.3390/ijms23041935] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Budimirovic DB, Protic DD. Fragile X Syndrome: Recent Research Updates toward Capturing Treatments’ Improvement in Clinical Trials. Brain Sciences 2022;12:1276. [DOI: 10.3390/brainsci12101276] [Reference Citation Analysis]
2 Gómez-rodríguez MJ, Morales-conejo M, Arteche-lópez A, Sánchez-calvín MT, Quesada-espinosa JF, Gómez-manjón I, Palma-milla C, Lezana-rosales JM, Pérez de la Fuente R, Martin-ramos M, Fernández-guijarro M, Moreno-garcía M, Alvarez-mora MI. Fragile X Syndrome Caused by Maternal Somatic Mosaicism of FMR1 Gene: Case Report and Literature Review. Genes 2022;13:1609. [DOI: 10.3390/genes13091609] [Reference Citation Analysis]
3 Curnow E, Wang Y. New Animal Models for Understanding FMRP Functions and FXS Pathology. Cells 2022;11:1628. [DOI: 10.3390/cells11101628] [Reference Citation Analysis]